Categories
rss

Risk of False Positive Lead Test Results with Certain Capillary Blood Collection Tubes Used with Magellan Diagnostics LeadCare Testing Systems – FDA Safety Communication

Murilo Freitas - 16:00, 26 de May de 2025146
FDA is alerting health care providers and lab staff of reports of false positives when using certain Micro Capillary Blood Collection tubes with the LeadCare Testing Systems.

http://www.fda.gov/medical-devices/safety-communications/risk-false-positive-lead-test-results-certain-capillary-blood-collection-tubes-used-magellan

 
Categories
rss

Esophagogastric Tube Recall: BD Issues Correction for Esophagogastric Balloon Tamponade Tubes due to Challenges Removing Plastic Plugs from Rubber Lumen

Murilo Freitas - 04:00, 22 de May de 2025136
Esophagogastric Tube Recall: BD Issues Correction for Esophagogastric Balloon Tamponade Tubes due to Challenges Removing Plastic Plugs from Rubber Lumen

http://www.fda.gov/medical-devices/medical-device-recalls/esophagogastric-tube-recall-bd-issues-correction-esophagogastric-balloon-tamponade-tubes-due

 
Categories
rss

Cetirizine or Levocetirizine: Drug Safety Communication – FDA Warns About Risk of Severe Itching After Discontinuation of Long-Term Use of Allergy Medicines

Murilo Freitas - 04:00, 22 de May de 2025116
The FDA is warning that patients stopping the oral allergy medicines cetirizine (Zyrtec) or levocetirizine (Xyzal) after long-term use may experience rare but severe itching. These medicines are available in prescription and over-the-counter (OTC) forms. The itching, also called pruritus, has been r

http://www.fda.gov/safety/medical-product-safety-information/cetirizine-or-levocetirizine-drug-safety-communication-fda-warns-about-risk-severe-itching-after

 
Categories
rss

UMARY- USA.COM Issues Voluntary Nationwide Recall of UNAVY ÁCIDO HIALURÓNICO Caplets and UMOVY ÁCIDO HIALURÓNICO Caplets Due to the Presence of Undeclared Drug Ingredients Dexamethasone, Diclofenac and Omeprazole

Murilo Freitas - 04:00, 21 de May de 2025168
FOR IMMEDIATE RELEASE – Date: May 21 2025, Nogales, AZ, UMARY USA is voluntarily recalling all lots of Unavy Ácido HIALURÓNICO (30 caplets/850 mg) and Umovy Ácido HIALURÓNICO (30 caplets/850 mg), to the consumer level. FDA laboratory analysis confirmed that these products are tainted with the drug i

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/umary-usacom-issues-voluntary-nationwide-recall-unavy-acido-hialuronico-caplets-and-umovy-acido

 
PRAIS 2.0